Oppenheimer downgraded Sutro Biopharma (STRO) to Perform from Outperform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STRO:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls
- Sutro Biopharma downgraded to Neutral from Overweight at Piper Sandler
- Sutro Biopharma double downgraded at BofA after luvelta deprioritized
- Sutro Biopharma downgraded to Underperform from Buy at BofA
Questions or Comments about the article? Write to editor@tipranks.com